img

Global Vortioxetine Hydrobromide Tablets Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vortioxetine Hydrobromide Tablets Market Insights, Forecast to 2034

Global Vortioxetine Hydrobromide Tablets market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Vortioxetine Hydrobromide Tablets industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Report Covers
This report presents an overview of global Vortioxetine Hydrobromide Tablets market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Vortioxetine Hydrobromide Tablets market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


H.Lundbeck A/S
Kanghong Pharmaceutical
Takeda Pharmaceuticals USA
Takeda Pharmaceutical
Zydus Pharms
CSPC Ouyi Pharmaceutical
Brilliant Pharmaceutical
Chiatai Tianqing
Sino Biopharmaceutical
Segment by Type
5mg
10mg
20mg

Segment by Application


Antidepressants
Anxiolytics

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Vortioxetine Hydrobromide Tablets plant distribution, commercial date of Vortioxetine Hydrobromide Tablets, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Vortioxetine Hydrobromide Tablets introduction, etc. Vortioxetine Hydrobromide Tablets Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Vortioxetine Hydrobromide Tablets
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Vortioxetine Hydrobromide Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.3 Market by Application
1.3.1 Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Antidepressants
1.3.3 Anxiolytics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vortioxetine Hydrobromide Tablets Sales Estimates and Forecasts 2018-2029
2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Region
2.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Region (2018-2024)
2.2.3 Global Vortioxetine Hydrobromide Tablets Revenue by Region (2024-2029)
2.2.4 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2018-2029)
2.3 Global Vortioxetine Hydrobromide Tablets Sales Estimates and Forecasts 2018-2029
2.4 Global Vortioxetine Hydrobromide Tablets Sales by Region
2.4.1 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Vortioxetine Hydrobromide Tablets Sales by Region (2018-2024)
2.4.3 Global Vortioxetine Hydrobromide Tablets Sales by Region (2024-2029)
2.4.4 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Vortioxetine Hydrobromide Tablets Sales by Manufacturers
3.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Manufacturers (2018-2024)
3.1.2 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vortioxetine Hydrobromide Tablets in 2022
3.2 Global Vortioxetine Hydrobromide Tablets Revenue by Manufacturers
3.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Manufacturers (2018-2024)
3.2.2 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Vortioxetine Hydrobromide Tablets Revenue in 2022
3.3 Global Key Players of Vortioxetine Hydrobromide Tablets, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Vortioxetine Hydrobromide Tablets Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vortioxetine Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Offered and Application
3.8 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vortioxetine Hydrobromide Tablets Sales by Type
4.1.1 Global Vortioxetine Hydrobromide Tablets Historical Sales by Type (2018-2024)
4.1.2 Global Vortioxetine Hydrobromide Tablets Forecasted Sales by Type (2024-2029)
4.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
4.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type
4.2.1 Global Vortioxetine Hydrobromide Tablets Historical Revenue by Type (2018-2024)
4.2.2 Global Vortioxetine Hydrobromide Tablets Forecasted Revenue by Type (2024-2029)
4.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Vortioxetine Hydrobromide Tablets Price by Type
4.3.1 Global Vortioxetine Hydrobromide Tablets Price by Type (2018-2024)
4.3.2 Global Vortioxetine Hydrobromide Tablets Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Vortioxetine Hydrobromide Tablets Sales by Application
5.1.1 Global Vortioxetine Hydrobromide Tablets Historical Sales by Application (2018-2024)
5.1.2 Global Vortioxetine Hydrobromide Tablets Forecasted Sales by Application (2024-2029)
5.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
5.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application
5.2.1 Global Vortioxetine Hydrobromide Tablets Historical Revenue by Application (2018-2024)
5.2.2 Global Vortioxetine Hydrobromide Tablets Forecasted Revenue by Application (2024-2029)
5.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Vortioxetine Hydrobromide Tablets Price by Application
5.3.1 Global Vortioxetine Hydrobromide Tablets Price by Application (2018-2024)
5.3.2 Global Vortioxetine Hydrobromide Tablets Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Vortioxetine Hydrobromide Tablets Market Size by Type
6.1.1 US & Canada Vortioxetine Hydrobromide Tablets Sales by Type (2018-2029)
6.1.2 US & Canada Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2029)
6.2 US & Canada Vortioxetine Hydrobromide Tablets Market Size by Application
6.2.1 US & Canada Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
6.2.2 US & Canada Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
6.3 US & Canada Vortioxetine Hydrobromide Tablets Market Size by Country
6.3.1 US & Canada Vortioxetine Hydrobromide Tablets Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
6.3.3 US & Canada Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Vortioxetine Hydrobromide Tablets Market Size by Type
7.1.1 Europe Vortioxetine Hydrobromide Tablets Sales by Type (2018-2029)
7.1.2 Europe Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2029)
7.2 Europe Vortioxetine Hydrobromide Tablets Market Size by Application
7.2.1 Europe Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
7.2.2 Europe Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
7.3 Europe Vortioxetine Hydrobromide Tablets Market Size by Country
7.3.1 Europe Vortioxetine Hydrobromide Tablets Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
7.3.3 Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Vortioxetine Hydrobromide Tablets Market Size
8.1.1 China Vortioxetine Hydrobromide Tablets Sales (2018-2029)
8.1.2 China Vortioxetine Hydrobromide Tablets Revenue (2018-2029)
8.2 China Vortioxetine Hydrobromide Tablets Market Size by Application
8.2.1 China Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
8.2.2 China Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Vortioxetine Hydrobromide Tablets Market Size by Type
9.1.1 Asia Vortioxetine Hydrobromide Tablets Sales by Type (2018-2029)
9.1.2 Asia Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2029)
9.2 Asia Vortioxetine Hydrobromide Tablets Market Size by Application
9.2.1 Asia Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
9.2.2 Asia Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
9.3 Asia Vortioxetine Hydrobromide Tablets Sales by Region
9.3.1 Asia Vortioxetine Hydrobromide Tablets Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Vortioxetine Hydrobromide Tablets Revenue by Region (2018-2029)
9.3.3 Asia Vortioxetine Hydrobromide Tablets Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Market Size by Type
10.1.1 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Market Size by Application
10.2.1 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Country
10.3.1 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Information
11.1.2 H.Lundbeck A/S Overview
11.1.3 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 H.Lundbeck A/S Recent Developments
11.2 Kanghong Pharmaceutical
11.2.1 Kanghong Pharmaceutical Company Information
11.2.2 Kanghong Pharmaceutical Overview
11.2.3 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Kanghong Pharmaceutical Recent Developments
11.3 Takeda Pharmaceuticals USA
11.3.1 Takeda Pharmaceuticals USA Company Information
11.3.2 Takeda Pharmaceuticals USA Overview
11.3.3 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Pharmaceuticals USA Recent Developments
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Information
11.4.2 Takeda Pharmaceutical Overview
11.4.3 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Takeda Pharmaceutical Recent Developments
11.5 Zydus Pharms
11.5.1 Zydus Pharms Company Information
11.5.2 Zydus Pharms Overview
11.5.3 Zydus Pharms Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Zydus Pharms Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zydus Pharms Recent Developments
11.6 CSPC Ouyi Pharmaceutical
11.6.1 CSPC Ouyi Pharmaceutical Company Information
11.6.2 CSPC Ouyi Pharmaceutical Overview
11.6.3 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSPC Ouyi Pharmaceutical Recent Developments
11.7 Brilliant Pharmaceutical
11.7.1 Brilliant Pharmaceutical Company Information
11.7.2 Brilliant Pharmaceutical Overview
11.7.3 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Brilliant Pharmaceutical Recent Developments
11.8 Chiatai Tianqing
11.8.1 Chiatai Tianqing Company Information
11.8.2 Chiatai Tianqing Overview
11.8.3 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chiatai Tianqing Recent Developments
11.9 Sino Biopharmaceutical
11.9.1 Sino Biopharmaceutical Company Information
11.9.2 Sino Biopharmaceutical Overview
11.9.3 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sino Biopharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vortioxetine Hydrobromide Tablets Industry Chain Analysis
12.2 Vortioxetine Hydrobromide Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vortioxetine Hydrobromide Tablets Production Mode & Process
12.4 Vortioxetine Hydrobromide Tablets Sales and Marketing
12.4.1 Vortioxetine Hydrobromide Tablets Sales Channels
12.4.2 Vortioxetine Hydrobromide Tablets Distributors
12.5 Vortioxetine Hydrobromide Tablets Customers
13 Market Dynamics
13.1 Vortioxetine Hydrobromide Tablets Industry Trends
13.2 Vortioxetine Hydrobromide Tablets Market Drivers
13.3 Vortioxetine Hydrobromide Tablets Market Challenges
13.4 Vortioxetine Hydrobromide Tablets Market Restraints
14 Key Findings in The Global Vortioxetine Hydrobromide Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 5mg
Table 3. Major Manufacturers of 10mg
Table 4. Major Manufacturers of 20mg
Table 5. Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Vortioxetine Hydrobromide Tablets Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Vortioxetine Hydrobromide Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Vortioxetine Hydrobromide Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2018-2024)
Table 10. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2024-2029)
Table 11. Global Vortioxetine Hydrobromide Tablets Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Vortioxetine Hydrobromide Tablets Sales by Region (2018-2024) & (Kg)
Table 13. Global Vortioxetine Hydrobromide Tablets Sales by Region (2024-2029) & (Kg)
Table 14. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2018-2024)
Table 15. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2024-2029)
Table 16. Global Vortioxetine Hydrobromide Tablets Sales by Manufacturers (2018-2024) & (Kg)
Table 17. Global Vortioxetine Hydrobromide Tablets Sales Share by Manufacturers (2018-2024)
Table 18. Global Vortioxetine Hydrobromide Tablets Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Vortioxetine Hydrobromide Tablets Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Vortioxetine Hydrobromide Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Vortioxetine Hydrobromide Tablets Price by Manufacturers 2018-2024 (US$/g)
Table 22. Global Vortioxetine Hydrobromide Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Vortioxetine Hydrobromide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vortioxetine Hydrobromide Tablets as of 2022)
Table 24. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Offered and Application
Table 26. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 29. Global Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 30. Global Vortioxetine Hydrobromide Tablets Sales Share by Type (2018-2024)
Table 31. Global Vortioxetine Hydrobromide Tablets Sales Share by Type (2024-2029)
Table 32. Global Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Vortioxetine Hydrobromide Tablets Revenue Share by Type (2018-2024)
Table 35. Global Vortioxetine Hydrobromide Tablets Revenue Share by Type (2024-2029)
Table 36. Vortioxetine Hydrobromide Tablets Price by Type (2018-2024) & (US$/g)
Table 37. Global Vortioxetine Hydrobromide Tablets Price Forecast by Type (2024-2029) & (US$/g)
Table 38. Global Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 39. Global Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 40. Global Vortioxetine Hydrobromide Tablets Sales Share by Application (2018-2024)
Table 41. Global Vortioxetine Hydrobromide Tablets Sales Share by Application (2024-2029)
Table 42. Global Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Vortioxetine Hydrobromide Tablets Revenue Share by Application (2018-2024)
Table 45. Global Vortioxetine Hydrobromide Tablets Revenue Share by Application (2024-2029)
Table 46. Vortioxetine Hydrobromide Tablets Price by Application (2018-2024) & (US$/g)
Table 47. Global Vortioxetine Hydrobromide Tablets Price Forecast by Application (2024-2029) & (US$/g)
Table 48. US & Canada Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 49. US & Canada Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 50. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 53. US & Canada Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 54. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Vortioxetine Hydrobromide Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Vortioxetine Hydrobromide Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Vortioxetine Hydrobromide Tablets Sales by Country (2018-2024) & (Kg)
Table 60. US & Canada Vortioxetine Hydrobromide Tablets Sales by Country (2024-2029) & (Kg)
Table 61. Europe Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 62. Europe Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 63. Europe Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 66. Europe Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 67. Europe Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Vortioxetine Hydrobromide Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Vortioxetine Hydrobromide Tablets Sales by Country (2018-2024) & (Kg)
Table 73. Europe Vortioxetine Hydrobromide Tablets Sales by Country (2024-2029) & (Kg)
Table 74. China Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 75. China Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 76. China Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 79. China Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 80. China Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 83. Asia Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 84. Asia Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 87. Asia Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 88. Asia Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Vortioxetine Hydrobromide Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Vortioxetine Hydrobromide Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Vortioxetine Hydrobromide Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Vortioxetine Hydrobromide Tablets Sales by Region (2018-2024) & (Kg)
Table 94. Asia Vortioxetine Hydrobromide Tablets Sales by Region (2024-2029) & (Kg)
Table 95. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Type (2018-2024) & (Kg)
Table 96. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Type (2024-2029) & (Kg)
Table 97. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Application (2018-2024) & (Kg)
Table 100. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Application (2024-2029) & (Kg)
Table 101. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2018-2024) & (Kg)
Table 107. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2024-2029) & (Kg)
Table 108. H.Lundbeck A/S Company Information
Table 109. H.Lundbeck A/S Description and Major Businesses
Table 110. H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 111. H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. H.Lundbeck A/S Recent Developments
Table 113. Kanghong Pharmaceutical Company Information
Table 114. Kanghong Pharmaceutical Description and Major Businesses
Table 115. Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 116. Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Kanghong Pharmaceutical Recent Developments
Table 118. Takeda Pharmaceuticals USA Company Information
Table 119. Takeda Pharmaceuticals USA Description and Major Businesses
Table 120. Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 121. Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Takeda Pharmaceuticals USA Recent Developments
Table 123. Takeda Pharmaceutical Company Information
Table 124. Takeda Pharmaceutical Description and Major Businesses
Table 125. Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 126. Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Takeda Pharmaceutical Recent Developments
Table 128. Zydus Pharms Company Information
Table 129. Zydus Pharms Description and Major Businesses
Table 130. Zydus Pharms Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 131. Zydus Pharms Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Zydus Pharms Recent Developments
Table 133. CSPC Ouyi Pharmaceutical Company Information
Table 134. CSPC Ouyi Pharmaceutical Description and Major Businesses
Table 135. CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 136. CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. CSPC Ouyi Pharmaceutical Recent Developments
Table 138. Brilliant Pharmaceutical Company Information
Table 139. Brilliant Pharmaceutical Description and Major Businesses
Table 140. Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 141. Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Brilliant Pharmaceutical Recent Developments
Table 143. Chiatai Tianqing Company Information
Table 144. Chiatai Tianqing Description and Major Businesses
Table 145. Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 146. Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Chiatai Tianqing Recent Developments
Table 148. Sino Biopharmaceutical Company Information
Table 149. Sino Biopharmaceutical Description and Major Businesses
Table 150. Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)
Table 151. Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Sino Biopharmaceutical Recent Developments
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Vortioxetine Hydrobromide Tablets Distributors List
Table 156. Vortioxetine Hydrobromide Tablets Customers List
Table 157. Vortioxetine Hydrobromide Tablets Market Trends
Table 158. Vortioxetine Hydrobromide Tablets Market Drivers
Table 159. Vortioxetine Hydrobromide Tablets Market Challenges
Table 160. Vortioxetine Hydrobromide Tablets Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Vortioxetine Hydrobromide Tablets Product Picture
Figure 2. Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Vortioxetine Hydrobromide Tablets Market Share by Type in 2022 & 2029
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 20mg Product Picture
Figure 7. Global Vortioxetine Hydrobromide Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Vortioxetine Hydrobromide Tablets Market Share by Application in 2022 & 2029
Figure 9. Antidepressants
Figure 10. Anxiolytics
Figure 11. Vortioxetine Hydrobromide Tablets Report Years Considered
Figure 12. Global Vortioxetine Hydrobromide Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vortioxetine Hydrobromide Tablets Revenue 2018-2029 (US$ Million)
Figure 14. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2018-2029)
Figure 16. Global Vortioxetine Hydrobromide Tablets Sales 2018-2029 ((Kg)
Figure 17. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Vortioxetine Hydrobromide Tablets Sales YoY (2018-2029) & (Kg)
Figure 19. US & Canada Vortioxetine Hydrobromide Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Vortioxetine Hydrobromide Tablets Sales YoY (2018-2029) & (Kg)
Figure 21. Europe Vortioxetine Hydrobromide Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Vortioxetine Hydrobromide Tablets Sales YoY (2018-2029) & (Kg)
Figure 23. China Vortioxetine Hydrobromide Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Vortioxetine Hydrobromide Tablets Sales YoY (2018-2029) & (Kg)
Figure 25. Asia (excluding China) Vortioxetine Hydrobromide Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales YoY (2018-2029) & (Kg)
Figure 27. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Vortioxetine Hydrobromide Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Vortioxetine Hydrobromide Tablets in the World: Market Share by Vortioxetine Hydrobromide Tablets Revenue in 2022
Figure 30. Global Vortioxetine Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 32. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 33. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 34. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Vortioxetine Hydrobromide Tablets Revenue Share by Country (2018-2029)
Figure 40. US & Canada Vortioxetine Hydrobromide Tablets Sales Share by Country (2018-2029)
Figure 41. U.S. Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 44. Europe Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 45. Europe Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 46. Europe Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 47. Europe Vortioxetine Hydrobromide Tablets Revenue Share by Country (2018-2029)
Figure 48. Europe Vortioxetine Hydrobromide Tablets Sales Share by Country (2018-2029)
Figure 49. Germany Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 50. France Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 54. China Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 55. China Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 56. China Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 57. China Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 58. Asia Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 59. Asia Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 60. Asia Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 61. Asia Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 62. Asia Vortioxetine Hydrobromide Tablets Revenue Share by Region (2018-2029)
Figure 63. Asia Vortioxetine Hydrobromide Tablets Sales Share by Region (2018-2029)
Figure 64. Japan Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 68. India Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Vortioxetine Hydrobromide Tablets Sales Share by Country (2018-2029)
Figure 75. Brazil Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Vortioxetine Hydrobromide Tablets Revenue (2018-2029) & (US$ Million)
Figure 80. Vortioxetine Hydrobromide Tablets Value Chain
Figure 81. Vortioxetine Hydrobromide Tablets Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries